Mawer Investment Management Ltd. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Mawer Investment Management Ltd. ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2021$112,047,000
+2.1%
1,280,972
-4.6%
0.50%
-4.2%
Q3 2021$109,755,000
-65.8%
1,342,072
-61.9%
0.53%
-66.9%
Q2 2021$321,047,000
-23.7%
3,518,714
-28.5%
1.59%
-30.4%
Q1 2021$420,500,000
-32.8%
4,919,280
-25.8%
2.28%
-38.1%
Q4 2020$625,655,000
-15.5%
6,625,594
-22.2%
3.69%
-23.8%
Q3 2020$740,498,000
+6.7%
8,515,391
+7.2%
4.84%
-5.4%
Q2 2020$693,916,000
+9.0%
7,944,991
+2.9%
5.12%
-12.7%
Q1 2020$636,623,000
+11.4%
7,721,327
+27.9%
5.86%
+26.5%
Q4 2019$571,627,000
+9.8%
6,036,824
+0.8%
4.63%
-2.8%
Q3 2019$520,565,000
-1.9%
5,990,387
+3.0%
4.76%
+38.7%
Q2 2019$530,871,000
-2.8%
5,813,946
+2.3%
3.43%
-11.7%
Q1 2019$546,138,000
+33.6%
5,680,653
+19.2%
3.89%
+14.6%
Q4 2018$408,841,000
+52.8%
4,764,486
+53.4%
3.39%
+68.8%
Q3 2018$267,652,000
+19.4%
3,106,449
+4.6%
2.01%
+11.0%
Q2 2018$224,237,000
-4.5%
2,968,452
+2.2%
1.81%
-7.9%
Q1 2018$234,729,000
+1.4%
2,903,267
+5.3%
1.97%
+2.7%
Q4 2017$231,576,000
+1.2%
2,758,166
+3.5%
1.92%
-1.8%
Q3 2017$228,812,000
+5.1%
2,665,258
+2.2%
1.95%
-2.8%
Q2 2017$217,617,000
-6.1%
2,607,125
-16.5%
2.01%
-10.3%
Q1 2017$231,876,000
+4.9%
3,122,065
+2.9%
2.24%
-1.0%
Q4 2016$220,957,000
-27.4%
3,033,455
-21.3%
2.26%
-29.2%
Q3 2016$304,256,000
-1.5%
3,853,289
+2.9%
3.19%
-26.8%
Q2 2016$308,906,000
+25.7%
3,743,858
+10.4%
4.36%
+53.0%
Q1 2016$245,723,000
-0.4%
3,392,085
+18.2%
2.85%
-10.1%
Q4 2015$246,813,000
+7.0%
2,868,583
+14.3%
3.17%
+0.3%
Q3 2015$230,721,000
+10.1%
2,510,016
+17.7%
3.16%
+18.5%
Q2 2015$209,634,000
+16.7%
2,131,730
+17.0%
2.67%
+16.3%
Q1 2015$179,687,000
+11.2%
1,822,197
+4.5%
2.29%
+9.8%
Q4 2014$161,640,000
+3.0%
1,744,438
+4.7%
2.09%
-0.5%
Q3 2014$156,863,000
+10.2%
1,666,412
+6.0%
2.10%
+11.0%
Q2 2014$142,373,000
+2.3%
1,572,498
-3.9%
1.89%
-4.3%
Q1 2014$139,144,000
+16.3%
1,636,860
+9.9%
1.98%
+13.2%
Q4 2013$119,593,000
+46.3%
1,489,263
+39.7%
1.75%
+33.0%
Q3 2013$81,739,000
+21.8%
1,065,783
+12.2%
1.31%
-47.5%
Q2 2013$67,135,000949,7632.50%
Other shareholders
NOVARTIS A G shareholders Q2 2015
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders